Drug class

Antidepressants Alpha-2 Receptor Antagonists

Alpha-2 receptor antagonist antidepressants, also commonly referred to in clinical literature as noradrenergic and specific serotonergic antidepressants (NaSSAs) or tetracyclic antidepressants like mirtazapine, are psychotropic agents used primarily in psychiatry. Read more about Antidepressants Alpha-2 Receptor Antagonists

28 drugs in this class 25 manufacturers

Advertisement

Drugs in Antidepressants Alpha-2 Receptor Antagonists

Showing 10–18 of 28 drugs

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
RISING PHARM

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
AVKARE

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
APHENA PHARMA S

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
A-S MEDICATION

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
GSMS, INC.

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
DIRECT RX

MIRTAZAPINE

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER
PROFICIENT RX L
Filter & compare in the drug finder → Opens the drug finder with Antidepressants Alpha-2 Receptor Antagonists preselected. Add indication or manufacturer filters there.

About Antidepressants Alpha-2 Receptor Antagonists.

Alpha-2 receptor antagonist antidepressants, also commonly referred to in clinical literature as noradrenergic and specific serotonergic antidepressants (NaSSAs) or tetracyclic antidepressants like mirtazapine, are psychotropic agents used primarily in psychiatry.

Their principal mechanism involves blocking central presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, thereby interrupting negative feedback loops and enhancing the synaptic release of both norepinephrine and serotonin.

They frequently display concurrent antagonist actions at postsynaptic serotonin 5-HT2 and 5-HT3 receptors, as well as histamine H1 receptors, contributing to sedative and appetite-stimulating effects.

Clinically, these agents are primarily indicated for major depressive disorder and are routinely used to manage depression characterized by insomnia, weight loss, or comorbid anxiety symptoms.